Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
13th Nov 2006, 19:52 GMT
At...
Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million related news:
- Precise Biometrics AB: Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million — Market Wire - Medical and Healthcare
- Stock issue of up to 3.4M shares approved by DayStar shareholders — Latest news from The Business Review (Albany)
- Another day, another all-time RIM stock high — BBHub
- Eaton Vance Credit Opportunities Fund Annual Meeting of Shareholders — DBusiness News - Boston
- Spectra Premium plans to buy out shareholders — thestar.com: Business Top Stories
- Shareholders Berate Share Reconstruction by Banks - Ask FG to Reduce Withholding Tax — AllAfrica News: Nigeria
- Nigeria: Shareholders Berate Share Reconstruction by Banks - Ask FG to Reduce Withholding Tax — AllAfrica News: Stock Markets
- Local News and Notes — Daily Herald Business
- Microsoft annual meeting — Todd Bishop's Microsoft Blog @ SeattlePI.com
- Formula shareholders turn down share distribution — Information technology |
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- PuriCore Plc announces Appointment
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL
- Study to Be Published in JAMA: Diabetes Drug ACTOS(R) (pioglitazone HCl) Halted Progression of Key Marker for Atherosclerosis; Improvements Indicated by Carotid Intima-Media Thickness (CIMT)